RIPK3 and Sepsis: Pharmacological inhibition of RIPK3 by GSK’872 accelerated the degradation of autophagosomes, induced the formation of autolysosomes, and thus alleviated tubular injury and improved renal function in sepsis-induced AKI (Li et al., 2021b).